Trenbolone Enanthate

VGL Fitness Tren Enanthate 200, a long-acting anabolic powerhouse designed for serious athletes chasing unmatched strength, mass and definition. Tren Enanthate 200 delivers lean gains, increased nitrogen retention and dramatic physique enhancements with fewer injections per week.

Trenbolone Enanthate – Harm Reduction Crib Sheet

Compound: Trenbolone Enanthate
Class: 19-Nor Anabolic-Androgenic Steroid (AAS)
Administration: Intramuscular injection (IM)

Dosage

• Performance Use: 200–400 mg/week
• Advanced Use: Up to 600 mg/week (not recommended for harm reduction)
• Not used therapeutically in humans

Half-Life

• ~7 to 10 days
• Injection frequency: Every 3 to 4 days (despite long ester, frequent dosing preferred for stable blood levels)

Benefits

• Extremely anabolic and androgenic
• Significant increases in strength and lean mass
• No oestrogenic conversion (does not aromatise)
• Increases nutrient partitioning and recovery
• Reduces catabolism during calorie deficit

Side Effects

• Progestin-related: Risk of gynecomastia even without aromatisation
• Androgenic: Severe acne, oily skin, aggression, hair loss
• Neurological: Insomnia, night sweats, anxiety, irritability
• Sexual dysfunction: Loss of libido or erectile issues (often dose-dependent)
• Suppression: Profound shutdown of natural testosterone
• Lipid impact: Severe HDL suppression, increased LDL
• Increased haematocrit: Elevated RBC and clotting risk

Risks

• Cardiovascular: Significant risk due to lipid profile changes and BP elevation
• Neurological/Psychological: Mood instability, irritability, “Tren rage” (exaggerated in some users)
• Pulmonary: “Tren cough” shortly after injection (transient)
• Reproductive: Testicular atrophy, infertility
• Hepatotoxicity: Mild (injectable), but elevated liver enzymes are possible

Risk Mitigation

• Bloodwork: Full labs including prolactin, TT/FT, E2, liver/kidney, CBC, lipids, BP monitoring
• Testosterone base: Always run with a test base to support function
• Prolactin management: Use Cabergoline only if levels are elevated (0.25 mg twice weekly)
• Lifestyle support: Cardiovascular exercise, high-fibre diet, omega-3s, antioxidant support
• Start low: Begin with 200 mg/week to assess tolerability
• Mental health monitoring: Discontinue if severe mood issues occur
• Hydration and sleep: Critical to reduce neurological strain

Post-Cycle Therapy (PCT)

If not transitioning to TRT

• Start: 14–21 days after last injection
• Tamoxifen (Nolvadex):
  • 40 mg/day (Weeks 1–2)
  • 20 mg/day (Weeks 3–4)
• Optional – Clomiphene (Clomid): 50 mg/day for 4 weeks
• Follow-up bloods: 6–8 weeks post-PCT (include prolactin and LH/FSH if recovery is delayed)